\BOOKMARK [0][-]{chapter.4}{Synthetic Lethal Analysis of Gene Expression Data}{}% 1
\BOOKMARK [1][-]{section.4.1}{Synthetic lethal genes in breast cancer}{chapter.4}% 2
\BOOKMARK [2][-]{subsection.4.1.1}{Synthetic lethal pathways in breast cancer}{section.4.1}% 3
\BOOKMARK [2][-]{subsection.4.1.2}{Expression profiles of synthetic lethal partners}{section.4.1}% 4
\BOOKMARK [3][-]{subsubsection.4.1.2.1}{Subgroup pathway analysis}{subsection.4.1.2}% 5
\BOOKMARK [1][-]{section.4.2}{Comparison of synthetic lethal gene candidates}{chapter.4}% 6
\BOOKMARK [2][-]{subsection.4.2.1}{Comparison with siRNA screen candidates}{section.4.2}% 7
\BOOKMARK [3][-]{subsubsection.4.2.1.1}{Comparison with correlation}{subsection.4.2.1}% 8
\BOOKMARK [3][-]{subsubsection.4.2.1.2}{Comparison with viability}{subsection.4.2.1}% 9
\BOOKMARK [3][-]{subsubsection.4.2.1.3}{Comparison with secondary screen siRNA screen candidates}{subsection.4.2.1}% 10
\BOOKMARK [3][-]{subsubsection.4.2.1.4}{Comparison of screen at pathway level}{subsection.4.2.1}% 11
\BOOKMARK [4][-]{subsubsubsection.4.2.1.4.1}{Resampling of genes for pathway enrichment}{subsubsection.4.2.1.4}% 12
\BOOKMARK [3][-]{subsubsection.4.2.1.5}{Comparison of candidate SL Pathways}{subsection.4.2.1}% 13
\BOOKMARK [1][-]{section.4.3}{Metagene Analysis}{chapter.4}% 14
\BOOKMARK [2][-]{subsection.4.3.1}{Pathway expression}{section.4.3}% 15
\BOOKMARK [2][-]{subsection.4.3.2}{Somatic mutation}{section.4.3}% 16
\BOOKMARK [2][-]{subsection.4.3.3}{Synthetic lethal metagenes}{section.4.3}% 17
\BOOKMARK [1][-]{section.4.4}{Mutation analysis}{chapter.4}% 18
\BOOKMARK [1][-]{section.4.5}{Global Synthetic Lethality}{chapter.4}% 19
\BOOKMARK [2][-]{subsection.4.5.1}{Hub Genes}{section.4.5}% 20
\BOOKMARK [2][-]{subsection.4.5.2}{Hub Pathways}{section.4.5}% 21
\BOOKMARK [1][-]{section.4.6}{Replication in stomach cancer}{chapter.4}% 22
\BOOKMARK [2][-]{subsection.4.6.1}{Synthetic Lethal Genes and Pathways}{section.4.6}% 23
\BOOKMARK [2][-]{subsection.4.6.2}{Synthetic Lethal Expression Profiles}{section.4.6}% 24
\BOOKMARK [2][-]{subsection.4.6.3}{Comparison to Primary Screen}{section.4.6}% 25
\BOOKMARK [3][-]{subsubsection.4.6.3.1}{Resampling Analysis}{subsection.4.6.3}% 26
\BOOKMARK [2][-]{subsection.4.6.4}{Metagene Analysis}{section.4.6}% 27
\BOOKMARK [1][-]{section.4.7}{Replication in cell line encyclopaedia}{chapter.4}% 28
\BOOKMARK [1][-]{section.4.8}{Summary}{chapter.4}% 29
\BOOKMARK [0][-]{section*.55}{References}{}% 30
\BOOKMARK [0][-]{appendix.A}{Sample Correlation}{}% 31
\BOOKMARK [0][-]{appendix.B}{Replicate Samples in TCGA Breast}{}% 32
\BOOKMARK [0][-]{appendix.C}{Software Used for Thesis}{}% 33
\BOOKMARK [0][-]{appendix.D}{Secondary Screen Data}{}% 34
\BOOKMARK [0][-]{appendix.E}{Mutation Analysis in Breast Cancer}{}% 35
\BOOKMARK [0][-]{appendix.F}{Expression Analysis in Stomach Cancer}{}% 36
\BOOKMARK [0][-]{appendix.G}{Mutation Analysis in Stomach Cancer}{}% 37
